Global Benign Prostatic Hyperplasia (BPH) Treatment Market Insights and Forecast to 2028

Publisher Name :
Date: 07-Mar-2022
No. of pages: 110
Inquire Before Buying

Benign Prostatic Hyperplasia (BPH) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia (BPH) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Drugs

- Devices

Segment by Application

- Hospitals

- Clinics

- Others

By Company

- Pfizer

- Sanofi

- GlaxoSmithKline

- Boston Scientific

- Teleflex

- Cardinal Health

- Allergan

- Teva Pharmaceutical

- Mylan

- Eli Lilly

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Benign Prostatic Hyperplasia (BPH) Treatment Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Perspective (2017-2028)
2.2 Benign Prostatic Hyperplasia (BPH) Treatment Growth Trends by Region
2.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Dynamics
2.3.1 Benign Prostatic Hyperplasia (BPH) Treatment Industry Trends
2.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
2.3.3 Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
2.3.4 Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue
3.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Revenue (2017-2022)
3.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Benign Prostatic Hyperplasia (BPH) Treatment Revenue
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio
3.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2021
3.5 Benign Prostatic Hyperplasia (BPH) Treatment Key Players Head office and Area Served
3.6 Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
3.7 Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Type
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2023-2028)
5 Benign Prostatic Hyperplasia (BPH) Treatment Breakdown Data by Application
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
6.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
6.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
6.2.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
6.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
6.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
6.3.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
6.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
6.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
6.4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
7.2.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
7.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
7.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
7.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
8.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
8.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region
8.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
9.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
9.2.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
9.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
9.3.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
9.4 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
9.4.1 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type
10.2.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application
10.3.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country
10.4.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.1.4 Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.2.4 Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.4.4 Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.4.5 Boston Scientific Recent Developments
11.5 Teleflex
11.5.1 Teleflex Company Details
11.5.2 Teleflex Business Overview
11.5.3 Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.5.4 Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.5.5 Teleflex Recent Developments
11.6 Cardinal Health
11.6.1 Cardinal Health Company Details
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.6.4 Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.6.5 Cardinal Health Recent Developments
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.7.4 Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.7.5 Allergan Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.9.4 Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.9.5 Mylan Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Introduction
11.10.4 Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
11.10.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs
Table 3. Key Players of Devices
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region (2017-2022)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region (2023-2028)
Table 10. Benign Prostatic Hyperplasia (BPH) Treatment Market Trends
Table 11. Benign Prostatic Hyperplasia (BPH) Treatment Market Drivers
Table 12. Benign Prostatic Hyperplasia (BPH) Treatment Market Challenges
Table 13. Benign Prostatic Hyperplasia (BPH) Treatment Market Restraints
Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Benign Prostatic Hyperplasia (BPH) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2021)
Table 17. Ranking of Global Top Benign Prostatic Hyperplasia (BPH) Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Benign Prostatic Hyperplasia (BPH) Treatment Product Solution and Service
Table 21. Date of Enter into Benign Prostatic Hyperplasia (BPH) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2017-2022)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2023-2028)
Table 31. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 64. Pfizer Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 65. Pfizer Recent Developments
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 69. Sanofi Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 70. Sanofi Recent Developments
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 74. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 75. GlaxoSmithKline Recent Developments
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 79. Boston Scientific Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 80. Boston Scientific Recent Developments
Table 81. Teleflex Company Details
Table 82. Teleflex Business Overview
Table 83. Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 84. Teleflex Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 85. Teleflex Recent Developments
Table 86. Cardinal Health Company Details
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 89. Cardinal Health Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 90. Cardinal Health Recent Developments
Table 91. Allergan Company Details
Table 92. Allergan Business Overview
Table 93. Allergan Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 94. Allergan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 95. Allergan Recent Developments
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 99. Teva Pharmaceutical Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 100. Teva Pharmaceutical Recent Developments
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 104. Mylan Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 105. Mylan Recent Developments
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Product
Table 109. Eli Lilly Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022) & (US$ Million)
Table 110. Eli Lilly Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Drugs Features
Figure 3. Devices Features
Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Benign Prostatic Hyperplasia (BPH) Treatment Report Years Considered
Figure 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share by Players in 2021
Figure 13. Global Top Benign Prostatic Hyperplasia (BPH) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Revenue in 2021
Figure 15. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Region (2017-2028)
Figure 35. China Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Benign Prostatic Hyperplasia (BPH) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 57. Boston Scientific Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 58. Teleflex Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 59. Cardinal Health Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 60. Allergan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 61. Teva Pharmaceutical Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 62. Mylan Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 63. Eli Lilly Revenue Growth Rate in Benign Prostatic Hyperplasia (BPH) Treatment Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs